Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF SEPTEMBER 03, 2009 FBO #2840
SOLICITATION NOTICE

B -- Pharmacokinetic Assessment

Notice Date
9/1/2009
 
Notice Type
Presolicitation
 
NAICS
621511 — Medical Laboratories
 
Contracting Office
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
 
ZIP Code
20857-0001
 
Solicitation Number
FDA1062753
 
Point of Contact
Jacqueline Richardson, , Doreen Williams,
 
E-Mail Address
jacqueline.richardson@fda.hhs.gov, doreen.williams@fda.hhs.gov
(jacqueline.richardson@fda.hhs.gov, doreen.williams@fda.hhs.gov)
 
Small Business Set-Aside
N/A
 
Description
Synopsis: The Food and Drug Administration intends to issue a Request for Quotes (RFQ) for Pharmacokinetic (PK) assessment of three extended release prescription products. With the introduction of Waxman-Hatch Act of 1984, the FDA has evaluated and approved thousands of therapeutic generic products as safe and equivalent to brand products. This is an enormous success story with some surveys estimating that about 65% of all prescriptions filled today are with generic products. Though successful, there is also a rising tide of skepticism about their safety and switch ability between products. Therefore, there is a need for an independent evaluation of some products with respect to their PK parameters. The objective of this contract is to provide: 1) to perform an independent evaluation of the PK of three extended release products at an academic clinical setting; and 2) to use this PK data to enhance their understanding on patient complaints and/or adverse events, and on their drug application reviews. The solicitation number for the procurement will be FDA-1062753 and the resultant award is expected is a Firmed Fixed Price Purchase Order with a period of performance of one (1) years. The requirements under the solicitation will be designated for Full and Open Competition. This will be be conducted under FAR Part 13. The RFQ will be posted on FedBizOpps (FBO) website: http://www.fbo.gov on or about September 14, 2009. All responsible sources may submit proposals which shall be considered by the agency. No bidder's list will be maintained. It is the offerors' responsibility to monitor the FedBizOpps for release of this acquisition and any associated amendments. Offeror must be registered in the Central Contract Registration (CCR) database before an award can be made to them. If the offeror is not registered in the CCR, it may be done so through the CCR website at http://www.ccr.gov.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA1062753/listing.html)
 
Place of Performance
Address: 5630 Fisher Lane, Rockville, Maryland, 20857, United States
Zip Code: 20857
 
Record
SN01935404-W 20090903/090902003642-588515a22b83f63044a7ba9d9fd2c2c0 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.